Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
256.80 CHF | -2.36% |
|
-0.31% | +0.51% |
Jul. 10 | ROCHE HOLDINGS AG : Buy rating from UBS | ZD |
Jul. 09 | Swiss Market Index Closes Higher; SGS Shares Down | MT |
Chart calendar Roche Holding AG
86a44a16efb004.bSBV7ohe_h2rFCzNjcpG3OSTtbNEaLXGtWQ9ZfUPt6c.WVIhp_oIqFnFXR7915V3mpf904A2GsahwC1fL4w65_Y7VxqauQmpW5oiHA~b922a285ff98558ffa1178c664ce7504
Upcoming events on Roche Holding AG
Past events on Roche Holding AG
Past dividends on Roche Holding AG
2025-03-26 | Annual 9.7 CHF |
2024-03-13 | Annual 9.6 CHF |
2023-03-15 | Annual 9.5 CHF |
2022-03-16 | Annual 9.3 CHF |
2021-03-17 | Annual 9.1 CHF |
2020-03-18 | Annual 9 CHF |
2019-03-06 | Annual 8.7 CHF |
2018-03-14 | Annual 8.3 CHF |
2017-03-15 | Annual 8.2 CHF |
2016-03-02 | Annual 8.1 CHF |
2015-03-04 | 8 CHF |
2014-03-05 | Annual 7.8 CHF |
2013-03-06 | Annual 7.35 CHF |
2012-03-07 | Annual 6.8 CHF |
2011-03-02 | Annual 6.6 CHF |
2010-03-03 | Annual 6 CHF |
2009-03-15 | Annual 5 CHF |
2008-03-06 | Annual 4.6 CHF |
2007-03-07 | Annual 3.4 CHF |
2006-03-01 | Annual 2.5 CHF |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 63 281 63 332 -0.08% | 58 716 59 502 -1.32% | 60 495 60 767 -0.45% | 62 680 | 65 131 | 67 171 |
EBITDA Million CHF | Released Forecast Spread | 25 015 24 644 1.51% | 21 976 22 765 -3.46% | 23 538 23 173 1.57% | 25 373 | 26 176 | 27 216 |
EBIT Million CHF | Released Forecast Spread | 22 173 22 200 -0.12% | 19 240 19 957 -3.59% | 20 823 20 819 0.02% | 22 112 | 22 896 | 24 008 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 16 327 19 694 -17.1% | 14 079 17 867 -21.2% | 11 793 16 940 -30.38% | 19 176 | 20 671 | 22 152 |
Net income Million CHF | Released Forecast Spread | 12 421 14 442 -13.99% | 11 498 13 584 -15.35% | 8 277 12 984 -36.25% | 13 614 | 14 691 | 15 870 |
EPS CHF | Released Forecast Spread | 15,4 17,9 -14.08% | 14,3 17,0 -15.74% | 10,3 16,6 -38.08% | 18,1 | 19,6 | 21,1 |
Announcement Date | 02/02/23 | 01/02/24 | 30/01/25 | - |
Quarterly results
Fiscal Period | December | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2026 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 14 457 14 534 -0.53% | 29 779 29 914 -0.45% | 14 274 14 256 0.13% | 14 663 14 938 -1.84% | 28 937 29 318 -1.3% | 14 399 14 370 0.21% | 15 449 13 153 17.46% | 29 848 29 689 0.54% | 15 136 14 914 1.49% | 15 511 15 341 1.11% | 30 647 30 647 -0% | 15 440 15 291 0.97% | 15 010 | 30 657 | 15 325 | 15 675 | 31 032 | 15 205 | 15 685 | 30 890 | 15 890 | 16 070 | 31 960 |
EBIT Million CHF | Released Forecast Spread | 10 911 11 057 -1.32% | 8 329 9 168 -9.15% | 11 293 10 409 8.49% | 9 530 9 673 -1.48% | 11 699 | 9 829 | |||||||||||||||||
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 9 174 10 510 -12.71% | 4 905 8 786 -44.17% | 8 223 8 930 -7.92% | 3 570 9 041 -60.51% | |||||||||||||||||||
Net income Million CHF | Released Forecast Spread | 7 137 7 896 -9.61% | 4 361 6 781 -35.69% | 6 258 7 294 -14.2% | 2 019 6 736 -70.02% | |||||||||||||||||||
EPS CHF | Released Forecast Spread | 8,87 9,42 -5.81% | 5,44 8,43 -35.47% | 7,80 8,91 -12.41% | 2,51 8,52 -70.54% | |||||||||||||||||||
Announcement Date | 27/07/23 | 27/07/23 | 01/11/23 | 01/02/24 | 01/02/24 | 25/04/24 | 25/07/24 | 25/07/24 | 30/10/24 | 30/01/25 | 30/01/25 | 24/04/25 | - | - | - | - | - | - | - | - | - | - | - |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-17 01:00 am | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
2025-07-22 | DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release |
2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release |
2025-07-23 01:00 am | COSMO PHARMACEUTICALS N.V.: Q2 2025 Earnings Release |
Past sector events for Roche Holding AG
2025-07-10 04:22 am | LOTUS PHARMACEUTICAL CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 07:51 pm | BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2025-07-09 04:26 am | YUNGSHIN GLOBAL HOLDING CORPORATION: June 2025 Sales and Revenue Release |
2025-07-09 04:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
2025-07-09 01:58 am | SYNMOSA BIOPHARMA CORPORATION: June 2025 Sales and Revenue Release |
2025-07-02 04:08 am | ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release |
2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-10 01:42 am | CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ROG Stock
- Calendar Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions